These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24210845)

  • 21. Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock.
    Llewelyn M
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S445-8. PubMed ID: 16237645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.
    Gupta-Malhotra M; Viteri-Jackson A; Thomas W; Zabriskie JB
    Exp Mol Pathol; 2004 Apr; 76(2):117-21. PubMed ID: 15010289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.
    Reglinski M; Sriskandan S
    Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein.
    Watanabe-Ohnishi R; Aelion J; LeGros L; Tomai MA; Sokurenko EV; Newton D; Takahara J; Irino S; Rashed S; Kotb M
    J Immunol; 1994 Feb; 152(4):2066-73. PubMed ID: 8120408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.
    Matsubara K; Fukaya T
    Curr Opin Infect Dis; 2007 Jun; 20(3):298-303. PubMed ID: 17471041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of superantigens in infections].
    Groeneveld PH
    Ned Tijdschr Geneeskd; 1994 Nov; 138(45):2235-8. PubMed ID: 7969608
    [No Abstract]   [Full Text] [Related]  

  • 27. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superantigens: microbial agents that corrupt immunity.
    Llewelyn M; Cohen J
    Lancet Infect Dis; 2002 Mar; 2(3):156-62. PubMed ID: 11944185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.
    Morita A; Imada Y; Igarashi H; Yutsudo T
    Microbiol Immunol; 1997; 41(11):895-900. PubMed ID: 9444333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyporesponsiveness of peripheral blood lymphocytes to streptococcal superantigens in patients with guttate psoriasis: evidence for systemic stimulation of T cells with superantigens released from focally infecting Streptococcus pyogenes.
    Tokura Y; Seo N; Ohshima A; Wakita H; Yokote R; Furukawa F; Takigawa M
    Arch Dermatol Res; 1999; 291(7-8):382-9. PubMed ID: 10482006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptococcal superantigens.
    Proft T; Fraser JD
    Chem Immunol Allergy; 2007; 93():1-23. PubMed ID: 17369697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
    Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
    Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis--as an autoimmune disease caused by molecular mimicry.
    Valdimarsson H; Thorleifsdottir RH; Sigurdardottir SL; Gudjonsson JE; Johnston A
    Trends Immunol; 2009 Oct; 30(10):494-501. PubMed ID: 19781993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superantigens: structure-function relationships.
    Baker MD; Acharya KR
    Int J Med Microbiol; 2004 Apr; 293(7-8):529-37. PubMed ID: 15149028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody responses to group A streptococcal infections in acute rheumatic fever.
    Martins TB; Veasy LG; Hill HR
    Pediatr Infect Dis J; 2006 Sep; 25(9):832-7. PubMed ID: 16940843
    [No Abstract]   [Full Text] [Related]  

  • 36. Superantigens: a brief review with special emphasis on dermatologic diseases.
    Solanki LS; Srivastava N; Singh S
    Dermatol Online J; 2008 Feb; 14(2):3. PubMed ID: 18700106
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo and in vitro detection of a superantigenic toxin Vbeta signature in two forms of streptococcal toxic shock syndrome.
    Thomas D; Perpoint T; Dauwalder O; Lina G; Floccard B; Richard JC; Bouvet A; Peyramond D; Allaouchiche B; Chidiac C; Vandenesch F; Etienne J; Ferry T
    Eur J Clin Microbiol Infect Dis; 2009 Jun; 28(6):671-6. PubMed ID: 19020908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A; Low DE; McGeer A; Kotb M
    Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
    [No Abstract]   [Full Text] [Related]  

  • 39. The cytokine response to streptococcal superantigens varies between individual toxins and between individuals: implications for the pathogenesis of group A streptococcal diseases.
    Proft T; Schrage B; Fraser JD
    J Interferon Cytokine Res; 2007 Jul; 27(7):553-7. PubMed ID: 17651016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcal pharyngitis and rheumatic heart disease: the superantigen hypothesis revisited.
    Hurst JR; Kasper KJ; Sule AN; McCormick JK
    Infect Genet Evol; 2018 Jul; 61():160-175. PubMed ID: 29530660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.